NEWS

Read UiM/EJU offline

UiM/EJU subscribers are now provided with a mobile digital issue of their journal. The eRef app enables you to comfortably read the latest journal issues on your tablet.

Find out more about the eRef app here

Use UiM/EJU offline • optimal reading experience • scalable font size • one click to download UiM/EJU


Ultrasound International Open

New open-access journal!

For author instructions and further information about publishing in UIO, visit www.thieme.com/uio


Impact Factor 2016

The Impact Factor 2016 for the EJU is 3.892


EFSUMB on FACEBOOK


SOCIETY NEWS

Prenatal Ultrasound and Autism: A Prediction Tool, a Risk Factor, Both or Neither?

Ensuring a favorable long-term neurodevelopmental outcome for the offspring has become a major objective in current Maternal – Fetal Medicine. To this end, autism remains a blind spot, and there are many reasons for this, including its clinical heterogeneity (autism spectrum disorders, ASD) and the lack of a single identifiable cause. Instead, various prenatal, perinatal and postnatal factors, often contradictory to each other, have been reported to statistically increase the risk for autism.


Read more »

 

Das Ultraschall-Screening für Männer ab 65 kommt – DEGUM begrüßt neue Richtlinie

Gute Neuigkeiten aus der Gesundheitspolitik: Gesetzlich krankenversicherte Männer ab 65 Jahren haben künftig Anspruch auf ein einmal durchgeführtes Ultraschall-Screening zur Früherkennung von Bauchaortenaneurysmen. Die entsprechende Richtlinie des Gemeinsamen Bundesausschusses (G-BA) ist nun zusammen mit einer Versicherteninformation in Kraft getreten. Die DEGUM sieht das als wichtigen Schritt an – empfiehlt jedoch auch Patienten mit einem besonderen Risikoprofil wie etwa Diabetes oder Rauchen sowie Frauen einzubeziehen.


Lesen Sie mehr »


FUTURE EUROSON CONGRESSES

More Information »


More information on all EUROSON Schools can be found on www.efsumb.org >>


Copyright, Ethics, Product Liability

Copyright

Submission of a manuscript to Ultraschall in der Medizin / European Journal of Ultrasound implies that it represents original research not previously published and that it is not being considered for publication elsewhere (see Guidelines for Authors). The corresponding author declares that the manuscript is submitted on behalf of all authors.

If your manuscript submitted to Ultraschall in der Medizin / European Journal of Ultrasound successfully passes the peer review, and is accepted by the editors of the journal, Thieme publishers acquire for the duration of the legal period of protection the exclusive right for the use of the rights of exploitation according to copyright laws, especially also the rights of translation, of publication in special issues, the use of individual passages of text for use in schools, the use for electronic text and visual image communication (also on-line, Internet), use in radio or television programmes, production of microcopies, renting or leasing for a fee or payment, duplication by photomechanical or similar means, storage in electronic databases as well as any other virtual storage and retrieval therefrom, in addition to any processing that may be necessary for the exploitation of the above-mentioned rights. Insofar as the above-mentioned rights are managed by an exploitation company the publisher is entitled to enter into the necessary contracts with the relevant exploitation companies; the publisher is also empowered to enter into contracts with third parties for the exploitation of these rights

Ethics

With the submission of the manuscript to Ultraschall in der Medizin / European Journal of Ultrasound you as the author confirm that all research involving intervention in human subjects or animals has received the approval of the institutional ethics commitee. If the institution has no formal ethics commitee, you confirm that the terms of the latest version of the Declaration of Helsinki for Medical Research involving Human Subjects have been adhered, and that experiments involving animals adhered to ethical standards.

Product Liability

Product liability laws place a heavy responsibility on you as the author of a scientific publication. This is especially the case when you report on therapeutic modalities and/or drug doses. Thus, please check these details in your manuscript very carefully. Depending on the degree of the theoretically possible dangers, please ask an experienced colleague or co-worker to also check on these details. During the editorial processing of your manuscript by the publisher it will be proof-read several times and, for example, details of doses carefully checked; however, only you as the author have the necessary specialist knowledge to assess the appropriateness of these details. The responsibility for their correctness lies exclusively with you as the author. Together with our authors we want to reduce the risk of possible injury to patients as well of damage claims and liability proceedings. For this we depend on your cooperation.